Whalegun
Home

Richard A. Heyman, Director: Enliven Therapeutics ELVN Sell · Filed 24/08/19

Trade details

Type
Insider sale
Amount
$14,833
Shares · price
650 sh · $22.82 a share
Held after
130,993 sh
Stock
Enliven Therapeutics ELVN
Person
Richard A. HeymanDirector
Trade date
24/08/15
Filed
24/08/19
Days to filing
4 days

Sold 0.5% of holdings

Share of holding sold
0.5%

Enliven Therapeutics trades, last 26 weeks

What else happened in Enliven Therapeutics around then

Filed or reported within 30 days of the trade day · 24/07/16~24/09/14

Richard A. Heyman's recent trades

  • Richard A. Heyman

    Planned sale10b5-1 planOric Pharmaceuticals

    $109.1K

    Filed 10/01

  • Richard A. Heyman

    Planned sale10b5-1 planOric Pharmaceuticals

    $102.4K

    Filed 10/01

  • Richard A. Heyman

    Planned saleEnliven Therapeutics

    $2.3M

    Filed 09/04

  • Richard A. Heyman

    Planned sale10b5-1 planOric Pharmaceuticals

    $84K

    Filed 07/06

  • Richard A. Heyman

    Planned sale10b5-1 planOric Pharmaceuticals

    $76.8K

    Filed 07/06

Richard A. Heyman, Director — sold $14.8K of Enliven Therapeutics ELVN · 0.5% of holdings · 10b5-1 plan | Whalegun